YOLFTbeta
Hyperion DeFi, Inc.

Hyperion DeFi, Inc.

HYPD · NASDAQ · Healthcare / Biotechnology

2.58USD-0.14 (-5.15%)

Price History

Full chart

Market Stats

Previous Close2.72
Open2.76
Day Range2.58 – 2.78
52-Week Range2.34 – 11.89
Volume200.50K
Market Cap62.78M
P/E (TTM)0.00
Forward P/E0.00
EPS-3.86
Dividend Yield0.00%
Beta2.53
50-Day Avg3.09
200-Day Avg3.39

About

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Hyunsu Jung
  • Employees9
  • Headquarters3090 Nowitzki Way, Dallas, TX, United States, 75219, USA
  • Websitehttps://hyperiondefi.com

Leadership

  • Mr. Hyunsu JungCEO, Chief Investment Officer & Director · b. 1996
  • Mr. David Knox C.F.A.Chief Financial Officer and Treasurer · b. 1990
  • Mr. Robert RubensteinGeneral Counsel & Secretary · b. 1967
  • Jason AssadInvestor Contact
  • Alexander LoboInvestor Contact

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.00M14.00M03.79K57.34K813.46K
Growth (%)-+600.00%-100.00%-+1414.02%+1318.75%
Cost of Revenue800.00K1.60M016.00K3.93M303.29K
Gross Profit1.20M12.40M0-12.22K-3.87M510.17K
Gross Margin60.00%88.57%--322.63%-6749.50%62.72%
Operating Expense20.99M25.42M26.91M25.39M44.87M19.49M
Operating Income-19.79M-13.02M-26.91M-25.41M-48.74M-18.98M
Operating Margin-989.46%-93.00%--670885.82%-85004.58%-2333.42%
EBITDA-19.69M-12.17M-26.32M-24.11M-46.21M-43.76M
EBITDA Margin-984.69%-86.92%--636547.06%-80587.33%-5379.11%
Net Income-19.77M-12.78M-28.01M-27.26M-49.82M-45.31M
Net Income Margin-988.49%-91.27%--719859.94%-86888.57%-5570.61%
R&D13.36M14.85M13.38M12.98M14.46M1.91M
R&D as % of Total Revenue668.16%106.08%-342641.46%25224.50%234.85%
Interest Expense17.04K387.76K1.38M2.37M2.48M1.56M
Interest Expense % of Total Revenue0.85%2.77%-62631.40%4333.11%191.50%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets33.91M31.66M31.04M28.78M3.67M51.76M
Total Liabilities18.60M11.19M13.80M19.78M16.76M10.70M
Total Equity15.30M20.47M17.23M9.00M-13.10M41.06M
Cash28.37M19.46M22.86M14.85M2.12M6.44M
Total Debt463.35K7.15M10.12M16.08M11.24M8.51M
Net Debt-27.91M-12.31M-12.74M1.23M9.12M2.07M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.38M-20.87M-25.11M-23.84M-30.12M-14.77M
Investing Cash Flow-261.26K-1.62M-874.75K-3.97M-161.48K-71.95M
Financing Cash Flow20.86M21.46M21.51M19.79M17.55M91.05M
Capital Expenditure261.26K1.62M874.75K3.97M161.48K4
Free Cash Flow-6.65M-22.49M-25.98M-27.81M-30.28M-14.77M
Dividends Paid----0892.17K
FCF to OCF104.09%107.75%103.48%116.66%100.54%100.00%
Dividend Paid to FCF----0.00%-6.04%

Earnings

Report DateMay 9, 2018Aug 14, 2018Nov 13, 2018Mar 27, 2019May 14, 2019Aug 12, 2019Nov 13, 2019Mar 25, 2020May 13, 2020Aug 12, 2020Nov 10, 2020Mar 25, 2021May 12, 2021Aug 11, 2021Nov 10, 2021Mar 28, 2022May 12, 2022Aug 10, 2022Nov 10, 2022Mar 30, 2023May 11, 2023Aug 10, 2023Nov 13, 2023Mar 18, 2024May 15, 2024Aug 13, 2024Nov 12, 2024Mar 26, 2025May 19, 2025Aug 11, 2025Nov 13, 2025Mar 26, 2026May 14, 2026Aug 12, 2026Nov 12, 2026
EPS Estimate-31.20-31.20-33.60-34.93-0.51-37.87-28.27-0.31-24.00-16.80-11.20-0.17-17.20-19.20-18.00-16.00-0.24-17.60-16.00-16.80-0.18-16.00-15.20-0.17-13.87-16.00-8.00-0.09-8.00-7.20-6.40-4.62-2.242.31
EPS Actual-36.00-26.40-34.40-48.00-0.50-35.20-23.20-0.31-24.80-20.00-18.40-0.17-16.80-15.20-18.528.00-0.24-17.60-16.80-13.60-0.15-12.80-14.40-0.18-15.31-14.20-8.80-16.44-1.59-2.500.05-6.290.260.92-
Surprise-15.38%15.38%-2.38%-37.42%1.96%7.05%17.93%0.00%-3.33%-19.05%-64.29%0.00%2.33%20.83%-2.89%150.00%0.00%0.00%-5.00%19.05%16.67%20.00%5.26%-5.88%-10.38%11.25%-10.00%-18166.67%80.13%65.31%100.78%-36.15%--58.93%-
TimingPre-marketPre-marketPre-marketPre-market-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours--After-hoursAfter-hoursPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap62.78M
Enterprise Value60.19M
Trailing P/E0.00
Forward P/E0.00
Price / Sales44.82
Price / Book0.60
EPS-3.86
Book Value6.66
Revenue (TTM)1.40M
Gross Profit (TTM)1.10M
EBITDA-17.45M
Profit Margin474.87%
Operating Margin-757.51%
Return on Equity9.55%
Return on Assets-11.06%
Shares Outstanding15.54M
Shares Float13.78M
Beta2.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
18.00%
Insiders
13.49%
Retail / Other
68.51%

Top Institutional Holders

  • Arrington Capital Management, LLC
    297.78K1.92%
  • Morgan Stanley - Brokerage Accounts
    237.99K1.53%
  • Redwood Wealth Management Group LLC
    183.27K1.18%
  • Almanack Investment Partners, LLC.
    169.01K1.09%
  • Jane Street Group LLC
    128.28K0.83%
  • Renaissance Technologies Corp
    115.64K0.74%
  • Vanguard Capital Management, LLC
    84.41K0.54%
  • BlackRock Inc
    81.11K0.52%
  • Geode Capital Management, LLC
    77.08K0.50%
  • Oppenheimer & Co Inc
    64.27K0.41%
  • Citadel Advisors Llc
    56.30K0.36%
  • UBS Group AG
    48.79K0.31%
  • Vanguard Fiduciary Trust Co
    28.15K0.18%
  • State Street Corp
    25.86K0.17%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    290.76K1.87%
  • Putnam Small Cap Value A
    286.63K1.84%
  • Putnam VT Small Cap Value IA
    111.37K0.72%
  • Fidelity Extended Market Index
    70.60K0.45%
  • Abante Quant Value FI
    36.00K0.23%
  • iShares Micro-Cap ETF
    33.77K0.22%

Stock Splits

  • Feb 3, 20251:80